- Previous Close
6.35 - Open
6.50 - Bid 6.20 x --
- Ask 6.21 x --
- Day's Range
6.20 - 6.40 - 52 Week Range
4.71 - 11.00 - Volume
22,379,848 - Avg. Volume
34,209,107 - Market Cap (intraday)
8.715B - Beta (5Y Monthly) 0.58
- PE Ratio (TTM)
-- - EPS (TTM)
-0.53 - Earnings Date --
- Forward Dividend & Yield 0.02 (0.24%)
- Ex-Dividend Date Jun 14, 2024
- 1y Target Est
--
Daan Gene Co., Ltd. researches and develops, manufactures, and sells clinical test reagents, instruments, and supporting consumables. The company offers fluorescence quantitative PCR products, enzyme-linked immunoassay products, instrument products, and scientific research service products. It also provides medical examination, and health consultation and management services, such as genetic susceptibility gene testing, tumor marker testing, cervical cancer screening, routine physical examination, and other health services. The company was formerly known as Da An Gene Co., Ltd. of Sun Yat-Sen University. The company was founded in 1988 and is headquartered in Guangzhou, the People's Republic of China.
www.daangene.comRecent News: 002030.SZ
View MorePerformance Overview: 002030.SZ
Trailing total returns as of 11/15/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 002030.SZ
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 002030.SZ
View MoreValuation Measures
Market Cap
8.91B
Enterprise Value
8.15B
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
9.58
Price/Book (mrq)
1.07
Enterprise Value/Revenue
8.77
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
-80.75%
Return on Assets (ttm)
-4.26%
Return on Equity (ttm)
-8.60%
Revenue (ttm)
929.61M
Net Income Avi to Common (ttm)
-750.65M
Diluted EPS (ttm)
-0.53
Balance Sheet and Cash Flow
Total Cash (mrq)
934.51M
Total Debt/Equity (mrq)
2.00%
Levered Free Cash Flow (ttm)
-971.22M